Английская Википедия:Iovance Biotherapeutics

Материал из Онлайн справочника
Версия от 20:01, 26 марта 2024; EducationBot (обсуждение | вклад) (Новая страница: «{{Английская Википедия/Панель перехода}} {{Short description|American biopharmaceutical startup}} {{More citations needed|date=November 2019}} {{Infobox company | name = Iovance Biotherapeutics, Inc. | logo = Iovance_Biotherapeutics_Logo.jpg | former_name = Lion Biotechnologies, Inc. | type = Public company | traded_as = {{ubl|class=nowrap|{{NASDAQ|IOVA}}|Russell 2000 component}} | predecessor = <!-- or: | predecessor...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:More citations needed Шаблон:Infobox company

Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.[1][2]

History

The company was founded in 2007 as Genesis Biopharma. In 2013, Lion merged with Genesis Biopharma аnd became lion bio Pharma, then rebranded to Iovance in 2017.[3]

In 2024 the US FDA gave accelerated approval for the company's tumor-infiltrating lymphocyte drug for the treatment of unresectable or metastatic melanoma.[4]

See also

References

Шаблон:Reflist

External links

Шаблон:Finance links

Шаблон:US-company-stub Шаблон:Med-company-stub